Evidence map›Paper›PMID 16948560›Full record

ReviewExpert opinion on drug delivery2006

Growth factor delivery for oral and periodontal tissue engineering.

Darnell Kaigler, Joni A Cirelli, William V Giannobile

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Expert opinion on drug delivery, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01663298 (FGF2 Promoter Hypermethylation and Implant Wound Healing Among Smokers and Diabetics), which is not on this map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01663298 completednot on this mapstarted 2010, after this paper: background citation

FGF2 Promoter Hypermethylation and Implant Wound Healing Among Smokers and Diabetics

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2010 to 2016Enrolled44ConditionsSmoking, DiabetesArmsDental implant surgery
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Applications of Growth Factors in Implant Dentistry.Current issues in molecular biology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Darnell KaiglerDepartment of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.
Joni A Cirelli
William V Giannobile
University of Michigan–Ann Arbor · USMichigan Center for Translational Pathology · US

Funding

GENE THERAPY FOR RECONSTRUCTING PERIODONTAL TISSUESR01DE013397 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIANNOBILE, WILLIAM V · 2000 to 2014
$4.0M
Periodontal Engineering Using Biomimetic Nano ScaffoldsR01DE015384 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MA, PETER X · 2003 to 2011
$2.9M
TNFR:Fc Gene Transfer for Treatment of PeriodontitisR21DE016619 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIANNOBILE, WILLIAM V · 2005 to 2006
$386k
PDGF-MEDIATED GENE TRANSFER &PERIODONTAL WOUND HEALINGR29DE011960 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIANNOBILE, WILLIAM V · 1997 to 2001
$239k
NIDCR NIH HHS DE 016619NIDCR NIH HHS R01 DE013397NIDCR NIH HHS R01 DE015384NIDCR NIH HHS R01-DE 015384NIDCR NIH HHS R01-DE-13397NIDCR NIH HHS R21 DE016619NIDCR NIH HHS R29 DE011960
6 · The paper itself

Abstract

The treatment of oral and periodontal diseases and associated anomalies accounts for a significant proportion of the healthcare burden, with the manifestations of these conditions being functionally and psychologically debilitating. Growth factors are critical to the development, maturation, maintenance and repair of craniofacial tissues, as they establish an extracellular environment that is conducive to cell and tissue growth. Tissue-engineering principles aim to exploit these properties in the development of biomimetic materials that can provide an appropriate microenvironment for tissue development. These materials have been constructed into devices that can be used as vehicles for delivery of cells, growth factors and DNA. In this review, different mechanisms of drug delivery are addressed in the context of novel approaches to reconstruct and engineer oral- and tooth-supporting structures, namely the periodontium and alveolar bone.

Indexed as

Drug Delivery SystemsGenetic TherapyTissue EngineeringAnimalsBecaplerminBone Morphogenetic Protein 7Bone Morphogenetic ProteinsGrowth SubstancesHumansMouth DiseasesPeriodontal DiseasesPlatelet-Derived Growth FactorProto-Oncogene Proteins c-sisRecombinant ProteinsTransforming Growth Factor betaWound HealingBecaplerminBMP7 protein, humanBone Morphogenetic Protein 7Bone Morphogenetic ProteinsGrowth SubstancesPlatelet-Derived Growth FactorProto-Oncogene Proteins c-sisRecombinant ProteinsTransforming Growth Factor beta

Identifiers

PMID16948560
PMCPMC2573469
OpenAlexW2140919529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.